Assessing the Accuracy of the RevK Sensor

University of California, San Francisco8 enrolled

Overview

Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.

Evaluation of a new generation of sensors for monitoring blood hemoglobin with the Masimo non-invasive hemoglobin monitor. The newest sensor version is RevK.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Patients Undergoing Spine Surgery

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or non-pregnant female * American Society of Anesthesiology Classification 1, 2 or 3 * Scheduled to undergo spine or hip surgery Exclusion Criteria: * Pregnant or nursing * Patients who in the study investigators clinical judgement would not be suitable for research

Locations (1)

University of California, San Francisco

San Francisco, California, United States

Outcomes

Primary Outcomes

To assess the accuracy of the RevK sensor for measuring blood hemoglobin compared to a laboratory-derived hemoglobin value.

Primary outcome is based on the difference between a value from the SpHb (Masimo SpHb™ continuous hemoglobin reading) minus tHb (laboratory hemoglobin determination).

Time frame: Intermittently during spine surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.